Cardiaccs, a Norwegian company developing innovative technology for direct monitoring of cardiac function, is pleased to announce the appointment of Mr. Shane West as Chief Executive Officer effective May 1st. Shane succeeds Prof. Erik Fosse who has been CEO since founding the company in 2009. Erik will continue to play a very active role in the company as Chairman of the Board of Directors.
Cardiaccs was founded in 2009 as a result of 8 years of research and development by the Intervention Centre at Oslo University Hospital in cooperation with Buskerud and Vestfold University College. In 2014, the company was granted funding by the Research Council of Norway through the FORNY2020 program to commercialize the Cardisense sensor technology. The appointment of Mr. Shane West will strengthen Cardiaccs ability to achieve regulatory approval and commercialise CardiSense with an increased focus on market and customer strategy.
Shane brings more than 15 years of global MedTech experience to Cardiaccs. He led the Customer and Market Insight function for the global GE Healthcare portfolio, where he helped drive customer-centric approaches to product and service development. Since leaving GE Healthcare at the end of 2016, Shane has focused his attention on supporting Norwegian startups and global MedTech leaders with customer and market insights through his VP of Client Relations EMEA position at Cetas Healthcare. Shane will continue in his role at Cetas Healthcare while taking on the role of CEO at Cardiaccs.
“Having come to know the CardiSense technology over the past 6 months I’m excited to be chosen to lead the company into its next exciting phase of commercialization,” said Shane West. “After listening to many physicians across the US and EU I’m convinced that CardiSense will be a valuable and sought-after monitoring tool for cardiac specialists”.
Shane has a BSc(Hons) in Cognitive Science and MBA from La Trobe University, Melbourne.
For more information please contact Cardiaccs via email@example.com or:
Non-profitt Inkubatoren Aleap er Norges største innovasjons og oppstarts miljø for gründere innen helse.Vårt mål er å forandre verden gjennom innovasjon, ved å utvikle et økosystem for oppstartsbedrifter innen helse, som gir ambisiøse entreprenører muligheten til å skape nye produkter og selskaper, bedre og raskere.
Vi gjør dette ved å tilby et bredt utvalg med viktig kunnskap og ekspertise, fleksibel infrastruktur og et internasjonalt forretningsnettverk. Vi mener at entreprenørskap og suksessfulle oppstartsselskap vil ha fordeler av å samarbeide i et tverrfaglig miljø hvor det å dele kunnskap er fundamentalt.